Mark Sullivan Biography and Net Worth

Mr. Sullivan is an experienced public company General Counsel and Corporate Secretary, with extensive expertise and demonstrated success in the areas of SEC reporting, financing, corporate governance and compliance, mergers and acquisitions, intellectual property, litigation management and business development. Prior to joining the Company, Mr. Sullivan was the General Counsel and Corporate Secretary of Sesen Bio, a biopharmaceutical company (prior to its merger with Carisma Therapeutics) (NASDAQ: CARM), from August 2019 to April 2023. Before that, he served as a private consultant to numerous life sciences companies. Previously, he served as the General Counsel, Chief Compliance Officer and Secretary of MModal Inc. (Nasdaq: MODL), formerly MedQuist, Inc., a leading healthcare IT company, until it was taken private by One Equity Partners, the private investment arm of JP Morgan Chase & Co. Prior to joining MModal, Mr. Sullivan was in private practice with Pepper Hamilton LLP and Drinker Biddle & Reath LLP. Mr. Sullivan received a B.A. from the University of Pennsylvania and a J.D. from the Rutgers University School of Law.

What is Mark Sullivan's net worth?: The estimated net worth of Mark Sullivan is at least $3.65 million as of September 25th, 2025. Mr. Sullivan owns 293,852 shares of Mind Medicine (MindMed) stock worth more than $3,652,580 as of December 5th. This net worth estimate does not reflect any other assets that Mr. Sullivan may own. Learn More about Mark Sullivan's net worth.
How old is Mark Sullivan?: Mr. Sullivan is currently 53 years old. There are 5 older executives and no younger executives at Mind Medicine (MindMed). The oldest executive at Mind Medicine (MindMed) is Dr. Miriam Halperin Wernli B.A., M.A., M.B.A., MBA, Ph.D., Executive President, who is 71 years old. Learn More on Mark Sullivan's age.
How do I contact Mark Sullivan?: The corporate mailing address for Mr. Sullivan and other Mind Medicine (MindMed) executives is , , . Mind Medicine (MindMed) can also be reached via phone at 650-208-2454 and via email at [email protected]. Learn More on Mark Sullivan's contact information.
Has Mark Sullivan been buying or selling shares of Mind Medicine (MindMed)?: Mark Sullivan has not been actively trading shares of Mind Medicine (MindMed) in the last ninety days. Most recently, Mark Sullivan sold 11,278 shares of the business's stock in a transaction on Thursday, September 25th. The shares were sold at an average price of $9.77, for a transaction totalling $110,186.06. Following the completion of the sale, the insider now directly owns 293,852 shares of the company's stock, valued at $2,870,934.04. Learn More on Mark Sullivan's trading history.
Who are Mind Medicine (MindMed)'s active insiders?: Mind Medicine (MindMed)'s insider roster includes Robert Barrow (Chief Executive Officer and Board Director), Schond Greenway (CFO), David Gryska (Director), Dan Karlin (Insider), Daniel Karlin (Insider), Carrie Liao (CAO), and Mark Sullivan (Insider). Learn More on Mind Medicine (MindMed)'s active insiders.
Are insiders buying or selling shares of Mind Medicine (MindMed)?: During the last twelve months, insiders at the sold shares 12 times. They sold a total of 149,022 shares worth more than $1,162,173.63. The most recent insider tranaction occured on September, 25th when insider Mark Sullivan sold 11,278 shares worth more than $110,186.06. Insiders at Mind Medicine (MindMed) own 2.5% of the company. Learn More about insider trades at Mind Medicine (MindMed).
Information on this page was last updated on 9/25/2025.

Mark Sullivan Insider Trading History at Mind Medicine (MindMed)

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/25/2025	Sell	11,278	$9.77	$110,186.06	293,852
6/25/2025	Sell	11,491	$6.80	$78,138.80	305,130

Mark Sullivan Buying and Selling Activity at Mind Medicine (MindMed)

Mind Medicine (MindMed) Company Overview

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.

Today's Range

Now: $12.43

$11.80

$12.55

50 Day Range

MA: $12.16

$10.67

$14.20

2 Week Range

Now: $12.43

$4.70

$14.43

Volume

1,199,690 shs

Average Volume

1,427,440 shs

Market Capitalization

$1.22 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.57

Mark Sullivan Biography and Net Worth

What is Mark Sullivan's net worth?

How old is Mark Sullivan?

How do I contact Mark Sullivan?

Has Mark Sullivan been buying or selling shares of Mind Medicine (MindMed)?

Who are Mind Medicine (MindMed)'s active insiders?

Are insiders buying or selling shares of Mind Medicine (MindMed)?